. 2012 Aug 14;107(6):956–960. doi: 10.1038/bjc.2012.353

Table 2. sHER2 levels at three different time points.

	sHER2 pre-chemotherapy		sHER2 after four cycles of chemotherapy		sHER2 before surgery
Baseline characteristics	Mean (ng ml ⁻¹ )	P-value	Mean (ng ml ⁻¹ )	P-value	Mean (ng ml ⁻¹ )	P-value
T3/4	17.7	<0.001	10.8	n.s.	9.9	n.s.
T1/2	11.1		10.3		9.9
G3	14.5	n.s.	10.8	n.s.	10.1	n.s.
G1/2	12.5		10.3		9.7
cN1	14.9	0.008	10.6	n.s.	9.8	n.s.
cN0	10.3		10.3		10.0
ER negative	15.6	<0.001	10.9	n.s.	9.8	n.s.
ER positive	11.6		10.2		9.9

Abbreviations: ER=oestrogen receptor; n.s.=not significant.